Product NDC: | 0056-0176 |
Proprietary Name: | COUMADIN |
Non Proprietary Name: | warfarin sodium |
Active Ingredient(s): | 2.5 mg/1 & nbsp; warfarin sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0056-0176 |
Labeler Name: | Bristol-Myers Squibb Pharma Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA009218 |
Marketing Category: | NDA |
Start Marketing Date: | 20090101 |
Package NDC: | 0056-0176-70 |
Package Description: | 1 BOTTLE in 1 CARTON (0056-0176-70) > 100 TABLET in 1 BOTTLE |
NDC Code | 0056-0176-70 |
Proprietary Name | COUMADIN |
Package Description | 1 BOTTLE in 1 CARTON (0056-0176-70) > 100 TABLET in 1 BOTTLE |
Product NDC | 0056-0176 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | warfarin sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090101 |
Marketing Category Name | NDA |
Labeler Name | Bristol-Myers Squibb Pharma Company |
Substance Name | WARFARIN SODIUM |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA] |